UKBizDB.co.uk

GLAXOSMITHKLINE CONSUMER HEALTHCARE IRELAND IP LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Glaxosmithkline Consumer Healthcare Ireland Ip Limited. The company was founded 10 years ago and was given the registration number FC032339. The firm's registered office is in DUNGARVAN. You can find them at Knockbrack, , Dungarvan, Co. Waterford. This company's SIC code is None Supplied.

Company Information

Name:GLAXOSMITHKLINE CONSUMER HEALTHCARE IRELAND IP LIMITED
Company Number:FC032339
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:26 January 2015
Jurisdiction:United - Kingdom
Industry Codes:
  • None Supplied

Office Address & Contact

Registered Address:Knockbrack, Dungarvan, Co. Waterford, Ireland, X35RY76
Country Origin:IRELAND
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
Shewalton Road, Irvine, United Kingdom, KA11 5AP

Corporate Secretary06 February 2015Active
980, Great West Road, Brentford, United Kingdom, TW8 9GS

Director12 July 2019Active
980, Great West Road, Brentford, TW8 9GS

Director13 May 2019Active
980, Great West Road, Brentford, United Kingdom, TW8 9GS

Director12 July 2019Active
980, Great West Road, Brentford, United Kingdom, TW8 9GS

Director06 February 2015Active
980, Great West Road, Brentford, United Kingdom, TW8 9GS

Director06 February 2015Active
980, Great West Road, Brentford, United Kingdom, TW8 9GS

Director31 January 2017Active
980, Great West Road, Brentford, United Kingdom, TW8 9GS

Director31 May 2015Active

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (3 months remaining)

Copyright © 2025. All rights reserved.